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     This study was carried out to identify the efficacy of Caparis spinosa root extract on promastigotes 
and amastigotes of Leishmania major. Caparis spinosa extracts were prepared. Promastogotes of  
L.major (1×10
6
 parasites/ml)were incubated at 26 ºC for 24,48 and 72hours in fresh medium(NNN), in 
absence or presence of different concentrations (0.1,0.3,0.5,0.7,0.9 mg/ml) of Caparis spinosa 
methanolic root extract. It was determined that anti-protozoal activity of Caparis extract (0.9 mg/ml) was 
similar to glucantime as a gold standard drug (p<0.05) and both were able to kill 97.8 % of 
promastigotes after72 hours. Microscopic observation showed that mainly complete lyses of 
promastigotes after treating with0.9 mg/ml of Caparis spinosa for72hours. Higher extract concentrations 
had more effect on promastigote population (p<0.05). It was demonstrated that Caparis sponosa root 
extract has positive effect on amastigotes of leishmania major. It was determined 0.7 mg/ml and 0.9 
mg/ml Caparis root extract concentrations were more effective than other concentrations on amastigots 
of Leishmania in ulcers. The mean of ulcer size of the mice that received 50 µl of 0.7 mg/ml and 0.9 
mg/ml Caparis root extract were less than mice receiving 0.1, 0.3 and 0.5. The mean of ulcer size of the 
mice that received 50 µl of 0.9 mg/ml Caparis spinosa root extract were significantly smaller than 
control group after six weeks(p<0.05) ,but the mean of ulcer size in mice which had been received 
glucantime (150 mg/ml)and Caparis root extract were not  significantly different (p>0.05). The results 
were suggestive that Caparis root extract had significantly similar effect in reduction of ulcer size as 
compared to glucantime (p<0.05). 
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INTRODUCTION 
     Leishmaniasis is transmitted through the bites 
of infected female phlebotomine sandflies all over 
the world except Australia and Antarctica. It is a 
disease with diver’s clinical symptoms which 
symptoms depend on both infecting species of 
Leishmania and host immune response. 
Cutaneous   leishmaniasis affects the skin 
membranes. Skin sores usually start at the site of 
the sand fly bite [1].Some kind of drugs such as 
pentamidine and amphotricine B are used in 
treatment, which maybe very toxic [2]. As a result 
of extensive interest in medicinal plants or their 
extracts all over the world many herbal extracts 
have been extensively used by native populations 
to treat leishmaniasis [3]. In the present study, the 
antileishmanial activity of Caparis extracts root 
was tested to validate the antiprotozoal properties 
of this plant. Caparis is a genus in the family 
Capparaceae which is included in the Brassicacea 
in the universe APGII system. Capparis spieces 
occurs   over a wide range of habitat in the 
subtropical and tropical zones. 
 
 MATERIALS AND METHODS 
 Preparation of plant extract: 
    The Caparis spinosa roots were dried in an 
oven with ventilation system at 30 °C. Then, the 
fluid extract was prepared by maceration for seven 
days using 80% ethanol as a solvent and 20% 
water, according to the Regulation Norm 309 
(Regulation Norm, 1992). Solvent was 
evaporated, and the extract was lyophilized, 
dissolved in dimethyl-sulfoxide (DMSO, BDH, 
England) at 20 mg/ml and stored at 4°C. 
Parasite culture (Promastigote) 
     Promastigotes of Leishmania major 
(MRHO/IR/75/ER strain) were maintained by 
RPMI-1640 medium supplemented with 10% 
bovine serum (FBS), 100 μg of Streptomycin/ml, 
 




and 100 U of Penicillin/ml, with passage each 3 or 
4 days at 26 ºC. Promastogotes of  L. major 
(1×10
6
 parasites/ml) were incubated at 26 ºC for 
24, 48 and 72 hours in fresh medium, in absence 
or presence of different concentrations (0.1, 0.3, 
0.5, 0.7, 0.9 mg/ml) of the methanolic extract of 
Caparis spinosa. The parasites were not used after 
10 in vitro passages. Inactive L. major 
promastigotes in the stationary growth phase were 
added to the plate well. A negative control (with 
Glucantime: 150 mg/ml) was included in the 
study. 
Parasite culture (Amastigote) 
   Leishmania major (MRHO/IR/75/ER strain) 
was cultured in NNN media and transferred to the 
enriched medium of RPMI1640 for mass 
production. It was given passage four times and 
Leptomonade forms were elevated to 
concentration of 1×107. L. major was injected 
subcutaneously at the base of tail of 70 inbred 
(BALB/c) mice female at the age of 8 weeks. 
The mice were assigned to the following 
groups: control group without receiving any 
extract, five groups receiving 0.1, 0.3, 0.5, 0.7, 
and 0.9 concentrations and one group were 
injected with Glucantime as gold standard drug 
for leishmaniasis. After appearance of the 
nodule at the site of parasite injection every day 
use of Caparis root extract for the groups 
initiated and the lesion   size were monitored 
weekly using vemiehcolise, respectively.  
This trend continued till the death of the last 
mice in the 15 week. Data were collected and 
analyzed with the statistics of ANOVA. 
Statistical analysis 
     All experiments were performed in triplicate. 
The mean and standard error of at least three 
experiments were determined. Statistical analysis 
of the differences between mean values 
obtained from experimental groups was done  
by means of students test P value of 0.05 or less 
were considered significant . 
 
RESULTS  
Effect of Caparis spinosa root extract on L. 
major promastigotes   
     The time course of the viability of L. major 
promastigotes in the absence or presence of 
Caparis spinosa root extract was shown in table 
1. It was determined that anti-protozoal activity 
of Caparis extract (0.9 mg/ml) was similar to 
Glucantime as a gold standard drug (p<0.05) 
and both were able to kill 97.8 % of 
promastigotes after 72 hours. The effect of 0.9 
mg/ml Caparis extract was significantly equal 
to Glucantime (p<0.05).Microscopic 
observation showed mainly complete lyses of 
promastigotes after treating with 0.9 mg/ml of 
Caparis spinosa for 72 hours. Extracts with 
higher concentration had more effect on 
promastigote population (p<0.05). The 
methanolic extract showed anti protozoal 
activity against developmental stages of L. 
major after 24, 48 and 72 hours of culture in 
fresh medium incubation. These results were 
corroborated by lyses of promastigote cells.  
Microscopic observation showed mainly 
complete lyses of promastigotes after treating 
with 0.9 mg/ml of Caparis spinosa for 72 hours. 
Extracts with higher concentration had more 
effect on promastigote population (p<0.05). The 
methanolic extract showed inhibitory activity 
against developmental stages of L. major after 
24, 48 and 72 hours of culture in fresh medium 
incubation. These results were corroborated by 
lyses of promastigote cells. 
 
 
Table1. Effect of different concentrations of Caparis spinosa   root extract on the number of promastigotes of Leishmania 
Extract concentrations and control Number of parasites 
 Beginning of 
culture 
24h 48h 72h 
Culture medium (Negative control) 380000 410000 420000 530000 
DMSO+PBS buffer 400000 390000 410000 500000 
Glucantime (Positive control) 450000 50000 20000 10000 
0.1mg/ml extract 480000 440000 410000 400000 
0.3mg/ml extract 475000 410000 380000 200000 
0.5mg/ml extract 470000 110000 90000 50000 
0.7mg/ml extract 460000 70000 25000 13000 









Effect of Caparis spinosa root extract on L. 
major amastigotes  
     In the next stage effect of Caparis spinosa 
root extract on amastigotes of Leishmania was 
studied. It was demonstrated Caparis spinosa 
root extract has positive effect on amastigotes of 
Leishmania major. It was determined that 0.7 
mg/ml and 0.9 mg/ml Caparis root extract 
concentrations were more effective than other 
concentrations on amastigotes of Leishmania in 
ulcers. Also it was shown a statistically 
significant difference between control group 
and treatment groups (p<0.05). The mean of 
ulcer size of the mice that received 50 µl of 0.7 
mg/ml and 0.9 mg/ml Caparis root extract were 
less than mice receiving 0.1, 0.3 and 0.5. The 
mean of ulcer size of the mice that received 50 
µl of 0.9 mg/ml Caparis spinosa root extract 
were significantly smaller than control group 
after six weeks (p<0.05), but there was not 
significant difference between the mean of ulcer 
size in mice which had been received 
Glucantime (120 mg/kg/day) and Caparis root 
extract (p>0.05). The results were suggestive 
that Caparis root extract had significantly 
similar effect in reduction of ulcer size as 
compared to Glucantime (p<0.05). 
 
DISCUSSION 
     Leishmaniasis is one of the most important 
infectious diseases in the world. There are wide 
differences in the clinical features of 
leishmaniasis. Cutaneous leishmaniasis is self-
healing while visceral leishmaniasis is fatal. 
There is a general lack of effective drug for 
treating leishmaniasis. Pentavalent antimonial 
drugs are the first line treatment for 
leishmaniasis in all of world. Then Amphotricin 
B and Pentamidine were used as alternative 
drugs [4]. These drugs are expensive and they 
also have side effect. In addition resistance to 
these compounds has become a serious 
problem. Therefore alternative medicines and 
herbal medicines were approved by scientist in 
the world.  
Furthermore, natural products are potential 
sources of new and selective agents for the 
treatment of important tropical diseases caused 
by protozoan and other parasites [5]. Only few 
laboratories are involved in drug evaluation and 
development against these devastating diseases, 
particularly against leishmaniasis, which has 
been considered as a “neglected disease” [6]. In 
this sense, the potential of plant extracts as a 
source of anti leishmanial drugs has been 
demonstrated. Several studies about screening 
of plants extracts against Leishmania have been 
reported [7-9].  
In Brazil one study described the screening of 
extracts obtained from 19 species of plants used 
in Brazilian traditional medicine for treatment 
of a variety of diseases. The extracts were tested 
against axenic amastigote and promastigote 
forms of Leishmania (L.) amazonensis and 
epimastigote forms of Trypanosoma cruzi in 
vitro at a concentration of 100 µg/ml Baccharis 
trimera, Cymbopogon citratus, Matricaria 
chamomilla, Mikania glomerata, Ocimum 
gratissimum, Piper regnellii, Prunus domestica, 
Psidium guajava, Sambucus canadensis, 
Stryphnodendron adstringens, Tanacetum 
parthenium and Tanacetum vulgare showed 
significant effects against one or both parasites, 
with a percentage of growth inhibition between 
49.5 and 99%. The extracts showed no 
cytotoxic effect on sheep erythrocyte [10]. 
Sharif in 2006, showed that methanolic extract 
of Artemisia aucheri inhibited the parasite 
multiplication at dose of 150, 300 and 450 
µg/ml at 48 and 72 hours of culture. Doses of 
600 and 750 µg/ml showed the same effect at 
24, 48 and 72 hours of culture (p<0.05). 
Methanolic extract of Camellia sinensis showed 
inhabitation of parasite multiplication when 
administered at doses of 150, 300, 450, 600 and 
750 µg/ml at 72 hours (p<0.05) [11]. Also, 
Mirzaie showed that Peganum harmala, or 
Syrian Rue, has pharmacologically active 
compounds including several alkaloids with anti 
protozoal properties, which are found especially 
in the seeds and the roots. In this research, 
Leishmania major were cultured in vitro, then 
by using a MTT assay, the biological activity of 
P. harmala extract in comparison to potassium 
antimonyl tartrate [Sb(III)] on L. major 
promastigotes was assessed. For P. harmala 
extract and Sb (III), the concentration-response 
curve was plotted, from which IC50 values 
were determined. Both P. harmala extract and 
Sb (III) inhibited the growth of promastigote 
forms of L. major in vitro after 72 h. of 
incubation and had an IC50 of 1832.65±89.72 
µg/ml and 17.87 ± 2.05 µg/mL, respectively. 
Statistical analysis of the results of the different 
concentrations of P. harmala extract and Sb 
(III) showed that there was no significantly 
difference between P. harmala extract and Sb 
(III) (P>0.05) but with a concentration increase 
 




of P. harmala extract or Sb (III), optical density 
decreased significantly, while inhibitory 
percentage increased. The different 
concentrations resulted in different optical 
densities or inhibitory percentages (P<0.05) so 
that P. harmala extract is effective against L. 
major [12]. Fatahi examined the effect of Rubia 
tinctorum extract on cutaneous leishmaniasis in 
BALB/c Mice. They found that the mean of 
lesion size of the mice that received 40, 60 and 
80% R. tinctorum extracts Showed no 
statistically significant difference compared the 
mean of the lesion size of the mice in control 
group (P>0.05) [13]. In Iran, it was shown 
effect of Alkanna tincturia and Peganum 
harmala extracts on Leishmania major. The 
results indicated that both extractions can 
inhibit the growth of promastigotes, and in 
concentrations of 40 µg/ml of P. harmala, 200 
µg/ml of A. tincturia, and 20 µg/ml of equal 
combination of P. hamala and A. tincturia is 
inhibitory concentration (IC50) for parasites 
growth. By adding these concentrations of the 
extracts to the infected macrophages in the 
culture, their effects were separately evaluated. 
The mean of amastigotes number in 
macrophages in the culture with P. harmala, A. 
ticturia, combination and control groups were 
0.7, 0.7, 0.6, 2.3 amastigotes per macrophage 
[14]. Singh investigated the anti-leishmanial 
properties of 30 medicinally important plants 
from the VL endemic area of Bihar, India and 
compared them to two available anti-
leishmanial drugs (Sodium Antimony 
Gluconate and Amphotericin B) and two plant 
lectins (Phytohemagglutinin and Concanavalin 
A) on Leishmania donovani promastigotes in 
vitro at 24 and 48 h after initiation of culture. 
They found eight plant extracts in addition to 
Phytohemagglutinin and Amphotericin B that 
significantly inhibited the growth of 
promastigotes (p<0.03). Also, it was determined 
minimum effective concentrations as well as 
effect on axenic amastigotes viability and the 
cell cytotoxicity on human peripheral blood of 
four (Agave americana, Azadirachta indica, 
Eclipta alba and Piper longum) of the eight 
plant extracts that induced significant 
promastigotes killing (p=0.00098). Effect-based 
dose finding analysis revealed that the threshold 
concentration of A. americana required to 
eliminate L. donovani after 24h was 0.05 
mg/ml. A. indica and P. longum plant extracts 
eliminated L. donovani promastigotes after 48 h 
at concentrations of 0.1 and 0.5 mg/ml, 
respectively. E. alba eliminated the 
promastigotes at a concentration of 0.5 mg/ml 
within 24h. The axenic amastigote killing 
response was 1.90-, 2.52- and 1.3-fold higher 
than the promastigote killing response with A. 
indica, A. americana and E. alba plant extracts, 
respectively. A. americana and A. indica, 
respectively, led to approximate 2.5- and 1.3- 
fold declines in mitochondrial dehydrogenase 
activity compared with control. E. alba 
stimulation resulted in an up-regulation of 
dehydrogenase activity (p<0.05). The CSA from 
P. longum was found to be least cytotoxic; the 
observed difference in mitochondrial activity 
was insignificant (p<0.05) [15]. Feily studied on 
ethanolic extract of the root of Echinacea 
purpurea prepared from Zardband 
Pharmaceutical Co. for its direct leishmanicidal 
activity in Leishmania culture. L. major 
promastigotes (stationary phase) were cultured 
in different concentrations of the extract (0.5–
125 mg/ml) for 30 min. Then the extract was 
removed and cell viability was determined 
during 120 h. LD50 for the promastigotes were 
determined as 22.3, 16.7, 3.66, 1.98 and 1.23 
mg at 8, 16, 24, 48 and 72 h respectively. The 
results showed the irreversible leishmanicidal 
activity of the E. purpurea. Findings showed 
that all concentrations of the extract had anti 
leishmanial effect and they’re useful for target 
cells [16]. Study of Soudi ,showed that 
ethanolic extract of Green tea has significant 
leishmanicidal activity against L. major 
promastigotes in different concentrations. There 
was a concordance in anti leishmanial effect of 
the ethanol extract with increasing of dosage (3, 
6, 12, 24, 48, 96 mg/ml). In comparison with 
Glucantime the mean alive promastigotes in 12 
mg/ml concentration of green tea was almost as 
same as 85 mg/ml Glucantime and higher green 
tea extract concentrations were higher effective 
than Glucantime. Study revealed a novel 
pharmacological activity against promastigotes 
of L. major and suggests that green tea extract 
has the potential of being used in leishmaniasis 
[17]. In Cuba , 48 alcoholic extracts from 46 
Cuban plants were evaluated by an in vitro 
bioassay against L. amazonensis. The three 
most potent extracts against the amastigote 
stage of L. amazonensis were from Hura 
crepitans, Bambusa vulgaris, and Simarouba 
glauca [18]. By Mostafa ,antihelminthic activity 
of Caparis spinosa extract on Lumbricus 
 




terrestris was carried out. This study showed 
that use of the aerial parts of C. spinosa as both 
the ethanolic and water extracts have 
antihelminthic activity. Furthermore, both type 
of extracts displayed significant antihelminthic 
properties at high concentrations and 
antihelminthic activities in a dose-dependent 
manner giving short time of paralysis and death 
of worm [19]. Camacho screened methanolic 
and aqueous extracts derived from 43 plant 
species, selected either from ethnobotanical or 
chemotaxonomical data, for their anti protozoal 
activity against Leishmania donovani and 
Trypanosoma brucei brucei. The cytotoxic 
activity against KB cells was also determined. 
IC50 value of eight extracts against L. donovani 
was less than 10 μg/ml. The most active 
was Triclisia patens with an IC50 value of 
1.5 μg/ml against L. donovani. Annona 
purpurea and Alstonia macrophylla had IC50 
values below 10 μg/ml against Trypanosoma 
brucei brucei. Annona purpurea was the most 
cytotoxic against KB cells [20]. 
As it was described, anti leishmanial effect of 
many plant groups in some parts of the world 
were determined. Over the last 15 years, interest 
in herbal medicines has increased worldwide in 
both developed and developing countries. Our 
results revealed a new pharmacological activity 
against L. major and suggest that Caparis 
spinosa root extract have the potential of being 
use as application in wound healing and also 
methanolic extract of Caparis spinosa showed 
inhibitory activity against development stages 
of L. major after 24, 48, 72 hours of culture in 
fresh medium incubation. The results presented 
able to be used in laboratory synthesis for 
development of new leishmanicidal agents 
using this plant. 
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